Surveying Local CAR-T Manufacturing Processes to Promote Standardization of Protocols

被引:0
|
作者
Gupta, Deven K. [1 ,2 ]
Shaz, Beth [1 ,2 ,3 ]
机构
[1] Duke Univ, Margolis Inst Hlth Policy, Durham, NC USA
[2] Duke Univ, Marcus Ctr Cellular Cures, Sch Med, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Pathol, Durham, NC USA
关键词
D O I
10.1182/blood-2024-210502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:7263 / 7264
页数:2
相关论文
共 50 条
  • [21] Automated End-to-End Manufacturing Solutions for Car-T Immunotherapies
    Shi, Yaling
    O'Conner, Joseph
    Dutta, Debargh
    McAfee, Erika
    Abraham, Eytan
    MOLECULAR THERAPY, 2018, 26 (05) : 426 - 426
  • [22] Revolutionary Selection, Activation, and Expansion with Microbubbles for CAR-T Cell Manufacturing
    Badea, Dominique
    Huang, Effie
    Snow, Tiffany
    Chen, Jesse
    Roussey, Jon
    Ku, Chia
    Wegner, Casey
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [23] RAPID DETECTION OF INTEGRATED VIRAL VECTORS DURING CAR-T MANUFACTURING
    Wiltshire, T.
    Milosevic, D.
    Grebe, S.
    Dietz, A.
    CYTOTHERAPY, 2021, 23 (05) : S193 - S193
  • [24] Automated end-to-end manufacturing solutions for CAR-T immunotherapies
    Shi, Y.
    O'Conner, J.
    Dutta, D.
    Abraham, E.
    HUMAN GENE THERAPY, 2018, 29 (12) : A122 - A122
  • [25] Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
    Zhang, Meng
    Jin, Xin
    Sun, Rui
    Xiong, Xia
    Wang, Jiaxi
    Xie, Danni
    Zhao, MingFeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [26] Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
    Meng Zhang
    Xin Jin
    Rui Sun
    Xia Xiong
    Jiaxi Wang
    Danni Xie
    MingFeng Zhao
    Journal of Translational Medicine, 19
  • [27] Investigating Whole Blood as a Starting Material for CAR-T Cell Manufacturing
    Traynor, Roshini
    Vignola, Bella A.
    Song, Hannah
    Sarkar, Sarmila
    Underwood, Sarah
    Prochazkova, Michaela
    Cai, Yihua
    Shi, Rongye
    Jin, Ping
    Somerville, Robert
    Stroncek, David F.
    Shah, Nirali
    Highfill, Steven
    MOLECULAR THERAPY, 2023, 31 (04) : 375 - 375
  • [28] Chimeric antigen receptor modified T cell (CAR-T) co-expressed with ICOSL-41BB promote CAR-T proliferation and tumor rejection
    Hu, Wei
    Huang, Xin
    Huang, Xingyue
    Chen, Wenwei
    Hao, Lidan
    Chen, Zubing
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [29] Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy
    Engels, Boris
    Zhu, Xu
    Yang, Jennifer
    Price, Andrew
    Sohoni, Akash
    Stein, Andrew M.
    Parent, Lana
    Greene, Michael
    Niederst, Matthew
    Whalen, Jeanne
    Orlando, Elena J.
    Treanor, Louise M.
    Brogdon, Jennifer L.
    BLOOD, 2021, 138
  • [30] Development and Clinical Validation of an Ultra-Fast CAR-T Manufacturing Platform Enabling Production of CAR-T Cells in Less Than 1 Day
    Stadel, Ryan
    Idippily, Nethrie
    Giraudo, Maria Florencia
    Caimi, Paolo
    Van Besien, Koen
    Martin, James
    Wu, John
    Deng, Changchun
    Wald, David
    BLOOD, 2023, 142